These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 33020931

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tadalafil ameliorates memory deficits, oxidative stress, endothelial dysfunction and neuropathological changes in rat model of hyperhomocysteinemia induced vascular dementia.
    Bhatia P, Singh N.
    Int J Neurosci; 2022 Apr; 132(4):384-396. PubMed ID: 32859137
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacological investigations on potential of peroxisome proliferator-activated receptor-gamma agonists in hyperhomocysteinemia-induced vascular dementia in rats.
    Sain H, Sharma B, Jaggi AS, Singh N.
    Neuroscience; 2011 Sep 29; 192():322-33. PubMed ID: 21777659
    [Abstract] [Full Text] [Related]

  • 10. Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats.
    Koladiya RU, Jaggi AS, Singh N, Sharma BK.
    BMC Pharmacol; 2008 Aug 09; 8():14. PubMed ID: 18691432
    [Abstract] [Full Text] [Related]

  • 11. Ameliorative Effect of a Selective Endothelin ETA Receptor Antagonist in Rat Model of L-Methionine-induced Vascular Dementia.
    Mangat GS, Jaggi AS, Singh N.
    Korean J Physiol Pharmacol; 2014 Jun 09; 18(3):201-9. PubMed ID: 24976759
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of Cilostazol a selective phosphodiesterase-3 inhibitor in rat model of Streptozotocin diabetes induced vascular dementia.
    Kumar A, Kumar A, Jaggi AS, Singh N.
    Pharmacol Biochem Behav; 2015 Aug 09; 135():20-30. PubMed ID: 25987325
    [Abstract] [Full Text] [Related]

  • 15. Ocimum Sanctum Linn: A Potential Adjunct Therapy for Hyperhomocysteinemia-Induced Vascular Dementia.
    Pasangulapati JP, Ravula AR, Kanala DR, Boyina S, Gangarapu K, Boyina HK.
    Adv Exp Med Biol; 2020 Aug 09; 1195():213-225. PubMed ID: 32468480
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neurobehavioral and neurobiochemical effect of atomoxetine and N-acetylcysteine in streptozotocin diabetes induced endothelial dysfunction and related dementia.
    Aggarwal H, Gupta S, Sharma P, Sharma BM, Sharma B.
    Physiol Behav; 2022 May 15; 249():113767. PubMed ID: 35245527
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.